However, clinical trials with higher CPAP adherence in patients with either type 2 diabetes (39, 40) or prediabetes (41, 42) have found that therapeutic CPAP improves glycemic control or insulin sensitivity compared to the control group. The gene discussed is INS; the disease is type 2 diabetes mellitus.